Scroll
The Japan-based GHIT Fund is an international public-private partnership fund for global health R&D
that mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics
for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.
LATEST NEWS
Why Global
Health R&D
Japan's Science and Pharmaceutical Capabilities for Global Health
Business
Model
World’s First Public-Private Partnership Fund for Global Health R&D
Investment
Opportunities
R&D Platforms and RFP Schedule
Investment to Date
since 2013
USD176M
Total Investment
86
Total Invested
Partnerships
Partnerships
119
Total Product
Development Partners
Development Partners
6
Clinical Trials